Vanderbilt University Medical Center, Nashville (United States of America)
Member of:
Lynne Warner Stevenson has been Director of Cardiomyopathy at UCLA, Brigham and Women’s Hospital, and now Vanderbilt University. She has contributed to >25 years of HF guidelines, including transplant, rhythm devices,and shared decisions. She served on the FDA Cardio-Renal panel, and as Associate Editor of Circulation,Circ Heart Failure,and JACC. Leadership roles include NHLBI-sponsored strategy studies such as ESCAPE, REMATCH and the HF Network Trials, and as a designer of INTERMACS and NCDR ICD registries. Her independent work has focused on decongestion, HF physiologic profiles, patient preferences, and dabbles in arrhythmogenic cardiomyopathy. She recently co-chaired ACC pathways for HF hospitalization and the NHLBI Call To Action for Ambulatory Stage C2D HF. She received the 2021 HFSA Lifetime Award and enjoys giving HF chalk-talks to providers at all levels, still seeking jewels of clarity in mountains of evidence and experience to personalize care for quality and length of life.